GALMED PHARMACEUTICALS LTD. Proceeds from Interest Received
GALMED PHARMACEUTICALS LTD. (GLMD) reported Proceeds from Interest Received of $1.19 million for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromInterestReceived · last filed 2021-03-18
| Period end | Proceeds from Interest Received 6 month | Proceeds from Interest Received 12 month |
|---|---|---|
| 2020-12-31 | $1.19M 20-F · filed 2021-03-18 | |
| 2020-06-30 | $317.00K 6-K · filed 2020-08-06 | |
| 2019-12-31 | $1.95M 20-F · filed 2021-03-18 | |
| 2019-06-30 | $1.06M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $865.00K 20-F · filed 2021-03-18 | |
| 2018-06-30 | $171.00K 6-K · filed 2019-08-05 | |
| 2017-12-31 | $202.00K 20-F · filed 2020-03-12 | |
| 2017-06-30 | $136.00K 6-K · filed 2018-08-02 | |
| 2016-12-31 | $382.00K 20-F · filed 2019-03-13 | |
| 2016-06-30 | $223.00K 6-K · filed 2017-07-31 | |
| 2015-12-31 | $473.00K 20-F · filed 2018-03-13 | |
| 2015-06-30 | $245.00K 6-K · filed 2017-06-23 | |
| 2014-12-31 | $0.00 20-F · filed 2017-03-23 | |
| 2013-12-31 | $0.00 20-F · filed 2016-03-22 |